Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
completed125%
terminated125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

OvS Breast: Ovarian Suppression in Breast Cancer Interventions

NCT06727487
recruitingphase_3

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

NCT06338683
terminatednot_applicable

Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain

NCT03944161
completednot_applicable

Effects of Exercise Intensity in Obese Children and Adolescents

NCT01991106

Clinical Trials (4)

Showing 4 of 4 trials
NCT06727487Not Applicable

OvS Breast: Ovarian Suppression in Breast Cancer Interventions

Recruiting
NCT06338683Phase 3

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Recruiting
NCT03944161Not Applicable

Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain

Terminated
NCT01991106Not Applicable

Effects of Exercise Intensity in Obese Children and Adolescents

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4